SCHEMBL25757863

SCHEMBL25757863

COC(=O)[C@@H]1C2C(CN1C(=O)CNc1c(F)cc(F)cc1F)C2(C)C

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 1/20 0.32
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24014601 1.00 FUCA1 (0.32) FUCA1CHRM3
SCHEMBL25757366 0.90 KDM1A (0.31) FUCA1
SCHEMBL25277355 0.80 CTSV (0.32)
SCHEMBL25277356 0.80 CTSV (0.32)
SCHEMBL25651167 0.77
SCHEMBL24015175 0.77 FUCA1 (0.34) FUCA1
SCHEMBL8284168 0.75
SCHEMBL25758173 0.72 CTSV (0.62)
SCHEMBL25757716 0.72 CTSV (0.62)
SCHEMBL8248147 0.72 MMP2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192660-A1 Protease Inhibitors for Treatment or Prevention of Coronavirus Disease UNIV LELAND STANFORD JUNIOR (US) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192660-A1 Protease Inhibitors for Treatment or Prevention of Coronavirus Disease ACE, ACE2, PEPD FUCA1 1308/4885CHRM3 3426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.